Promoting Science & Technology for Caribbean Youth
CADSTI-NE is a non-profit 501(c)(3) organization that supports the work of the Caribbean Science Foundation (CSF) by mobilizing the Caribbean Diaspora in the northeastern United States. While the Caribbean Science Foundation conducts workshops for science students (and teachers), summer science programs such as SPISE, student science competitions and other activities in the Caribbean, CADSTI-NE supports the CSF's activities by seeking financial support and sponsoring internships for Caribbean students at U.S. biotech and high tech companies.
Dr. Dinah Sah is President and Director of CADSTI-New England. She is also a member of the Caribbean Science Foundation’s (CSF) Governing Council and co-directs the CSF’s Student Program for Innovation in Science and Engineering (SPISE). SPISE is an annual intensive four-week enrichment residential summer program held at the University of West Indies in Barbados for promising Caribbean high-school students 16 to 17 years of age who are interested in pursuing careers in science and engineering. Dr. Sah has more than 20 years of experience in research and drug development in the biotechnology industry, and is currently Senior Vice President of Neuroscience at Voyager Therapeutics, a start-up biotech company in Cambridge, MA. Prior to Voyager, Dr. Sah served at Alnylam Pharmaceuticals where she was Vice President of Research, Biogen (now Biogen Idec), and Signal Pharmaceuticals. Her accomplishments include leadership of multiple programs from early research through Phase 1 clinical trials, and the discovery of novel therapeutic targets and drug candidates that advanced into clinical development. Most recently, her leadership of drug discovery programs based on RNAi therapeutics resulted in the landmark demonstration of human proof-of-mechanism for this novel class of drugs in patients. Dr. Sah received a B.S. in Biology from MIT, her Ph.D. in Neurobiology from Harvard University, and her post-doctoral training at Harvard Medical School.
Dr. Cardinal Warde is a Director of CADSTI-New England. He is also President of CADSTI and the Interim Executive Director of the Caribbean Science Foundation. Dr. Warde is Professor of Electrical Engineering at the Massachusetts Institute of Technology, where he has served on the faculty since 1974. His research activities are centered on the development of: (1) compact optoelectronic neural network co-processors for brain-like computing, (2) light modulators based on micro-electro-mechanical-systems for optical switching and projection displays, and (3) high-resolution adaptive wavefront phase compensation systems for imaging and optical communications. In addition to his undergraduate and graduate teaching responsibilities, Professor Warde’s commitment to young people is reflected in his role since 1997 as the Faculty Director of the MITES program at MIT, a six-week intensive program in science and engineering for gifted under-represented minority high-school seniors. As an entrepreneur, Dr. Warde founded Optron Systems, Inc. in 1982, and then in 1999 co-founded Radiant Images, Inc. which was subsequently acquired by Hoya Corp. of Japan. Professor Warde has published over 150 technical papers on optical materials, devices and systems as well as 3 book chapters, and also has co-edited a book on optical materials. He is the holder of 12 patents on spatial light modulators, displays and optical information. Dr. Warde was born in Barbados. He received his B.S. in Physics from Stevens Institute of Technology and his Ph.D. in Physics from Yale University.
Dr. Tony Rossomando is a Director of CADSTI-New England and Treasurer. He is also Vice Preseident of Analytical Development at Synageva BioPharma in Lexington MA. He is biologic drug developer in the Biotech industry with over 18 years of experience and key strengths in a solid understanding of biotherapeutics. He is currently Senior Director at Synageva BioPharm. In addition, he holds the position of Adjunct Associate Professor at Northeastern University in the Center for Drug Discovery where he has taught pharmacokinetics. He has also previously taught protein biochemistry and enzymology at the University of New Haven in Connecticut. Dr. Rossomando's experience includes assay development, bioanalytical development, protein chemistry, protein isolation, protein conjugation, peptide characterization, biologic and small molecule drug discovery, pharmacokinetics/pharmacodynamics, staff development and project management. He has successfully lead three projects into development with one project entering Phase I clinical development, and has assisted in an IND filing for initiation of a Phase I clinical trial. Dr. Rossomando's broad expertise spans early research to pre-clinical development projects across several therapeutic areas including Neuroscience, Metabolic Diseases, and Oncology. Dr. Rossomando received a B.S. in Biology with a minor in Chemistry from SUNY Stony Brook, his Ph.D. from the University of Virginia, and his post-doctoral training at Cold Spring Harbor.
Dr. Paul McLean is Vice President of CADSTI-NE. He is also a Senior Scientist at Shire Pharmaceuticals, a biotechnology company located in Lexington, MA. Dr. McLean is a biochemist with over 20 years of experience in industry conducting research and development of protein therapeutics and small molecules. He has extensive multi-disciplinary research experience in protein biochemistry / enzymology, cell biology, immunology and molecular biology. His current activities focus on the development of analytical methods for recombinant proteins, including especially the discovery of new analytical technologies for application to rare diseases. Dr. McLean was born in Barbados and educated at Harrison College in Barbados, He was a Barbados National Scholar and pursued post-secondary biochemistry studies in England. Dr. McLean received a B.S. from the University of Birmingham, his PhD from the University of Sussex, and his post-doctoral training in protein characterization in the chemistry department at MIT and in immunology at Tufts University.
Dr. Richard Fauconier is the Secretary of CADSTI-New England. He is also an electrical engineer and former physics teacher, with more than a decade of experience in various aspects of electronics and embedded computing. He has created radar algorithms for target discrimination and tracking, wavelet-based algorithms for the recognition of chemicals on surfaces by their diffusely reflected infrared spectra, digital signal processing algorithms for the recognition of disturbed earth by machine analysis of scattered infrared spectra, and DSP algorithms for automatic noise reduction in audio and communication systems. Before becoming an engineer, Dr. Fauconier was a mathematics and physics teacher in Trinidad, West Indies, a physics and electronics teacher in Brooklyn, New York, USA, and an adjunct professor in computer communications at New York City Technical College. Since arriving in New England, he has been a volunteer in education causes in the Greater Boston area. Dr. Fauconier received his B.Sc. in Physics from the University of the West Indies, his M.S. in Electrical Engineering from Polytechnic University (now New York University's School of Engineering) and his Ph.D. in electrical engineering from Rensselaer Polytechnic Institute.
*CADSTI-New England is a United States-Based Non-Profit 501 (c) (3) Organization